Dyno Nobel (ASX:DNL) has completed the sale of its fertilisers distribution business to Ridley Corporation, receiving upfront proceeds of $381 million, with additional purchase price adjustments ...

Eagers Automotive (ASX:APE) has unveiled a $1 billion expansion into Canada through a strategic investment in CanadaOne Auto, one of the country's largest dealership groups. Under the proposal, Eagers ...

VEEM (ASX:VEE) has completed a $14 million placement of fully paid ordinary shares to institutional and sophisticated investors, aimed at accelerating its growth in the defence sector. The placement, ...

Radiopharm Theranostics (ASX:RAD), a clinical-stage biopharmaceutical company specialising in innovative oncology radiopharmaceuticals, announced today a research and option agreement with Starpharma ...

The economics of crypto mining have shifted due to rising electricity costs and declining profitability from reduced Bitcoin (CRYPTO:BTC) mining rewards. Many mining firms are now moving into AI data ...

หน่วยงานนี้ยังควบคุมบริษัทสินทรัพย์ดิจิทัล เช่น Coinbase, Circle และ Paxos ภายใต้กรอบการทำ BitLicense ของรัฐนิวยอร์ก การนำของ Harris วางตำแหน่ง ...

Amplia Therapeutics (ASX:ATX) has received notice from the US Patent and Trademark Office allowing a key patent for its lead FAK inhibitor, narmafotinib, with formal grant expected in the coming ...

Mounting concerns over U.S. fiscal policy are driving fresh interest in digital assets as potential safe-haven investments. Investor anxiety has grown as the U.S. national debt surpassed $37.6 ...

PolyNovo (ASX:PNV) has confirmed its NovoSorb products, including the Biodegradable Temporising Matrix and NovoSorb MTX, will not be subject to the 100% tariff on pharmaceutical products announced by ...

Alcoa Corporation (ASX:AAI) will permanently close its Kwinana alumina refinery in Western Australia, ending more than six decades of operations at the site. The decision follows the curtailment of ...

SeaStar Medical (NASDAQ:ICU) has announced encouraging preliminary outcomes from its SAVE Surveillance Registry evaluating the QUELIMMUNE therapy for treating pediatric Acute Kidney Injury (AKI), ...

Johnson & Johnson (NYSE:JNJ) today announced a significant expansion for its drug TREMFYA® (guselkumab), which has received approval from the U.S. Food and Drug Administration (FDA) to treat children ...